Author

S. Barman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5 Biochemistry· 2 Bioengineering· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 8 Research Focus:host-pathogen & immune response· 7 Organism:human· 5 Organism:mouse· 5 Assay:proteomics· 5 Research Focus:cell type annotation· 2 Approach:statistical model· 2 Approach:biophysical modeling· 1

Frequent Co-Authors

F. Zhao· 5 shared A. Burns· 4 shared D. Sok· 4 shared D. J. Dowling· 3 shared L. Peng· 3 shared M. Ricciardi· 3 shared O. Limbo· 3 shared A. B. Ward· 2 shared

Activity by Year

2021-2025 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersBioengineering

F. Zhao

Mutual co-authors in cluster

Author profile →

10 papers

Recent·Most cited

Immune-profiling of T helper 1 (Th1), Th2 and Th17 signatures in murine splenocytes by targeting intracellular cytokines

S. Barman, A. Kelly, D. Dong, A. Patel, M. J. Buonopane, J. Gonzales, B. Janoschek, A. Draghi, D. J. Dowling

The paper develops a 17-parameter spectral flow cytometry panel to profile Th1, Th2, and Th17 cytokine signatures in murine splenocytes under steady-state and stimulated conditions.

Cytometry Part A · Mar 17, 2025Peer-reviewedImmunology

Olive phenolic compounds, potent tankyrase 1 inhibitor exhibit anti colon cancer effects by blocking Wnt/β-catenin pathway

A. Sain, S. Barman, D. Khamrai, M. Srinivas, P. Singh, B. Simpi, M. Varshney, D. Naskar

This study identifies olive polyphenols as tankyrase 1 inhibitors that suppress the Wnt/β-catenin pathway, reducing colon cancer cell viability and target gene expression.

bioRxiv · May 8, 2024 · PreprintCancer Biology

Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance.

T. R. O'Meara, E. Nanishi, M. E. McGrath, S. Barman, D. Dong, C. Dillen, M. Menon, H.-S. Seo, S. Dhe-Paganon, R. K. Ernst, O. Levy, M. B. Frieman, D. J. Dowling

bioRxiv · Dec 7, 2022Immunology

Shaping neonatal immunization by tuning delivery of synergistic adjuvants via nanocarriers

S. Barman, F. Borriello, B. Brook, C. Pietrasanta, M. De Leon, C. Sweitzer, M. Menon, S. D. van Haren, D. Soni, Y. Saito, E. Nanishi, S. Yi, S. Bobbala, O. Levy, E. A. Scott, D. J. Dowling

This study identifies synergistic adjuvants for neonatal immunization using nanocarriers, showing enhanced Th1 bias and humoral responses in mice.

bioRxiv · Jun 3, 2022Immunology

Molecular Insights into the Recognition of Acetylated Histone Modifications by the BRPF2 Bromodomain

S. Barman, A. Roy, J. Padhan, B. Sudhamalla

This study identifies novel acetyllysine-binding interactions of the BRPF2 bromodomain with histone modifications, revealing its role in recruiting the HBO1 HAT complex to chromatin.

bioRxiv · Feb 20, 2022Biochemistry

Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape

F. Zhao, C. Keating, G. Ozorowski, N. Shaabani, I. M. Francino-Urdaniz, S. Barman, O. Limbo, A. Burns, P. Zhou, M. Ricciardi, J. Woehl, Q. Tran, H. L. Turner, L. Peng, D. Huang, , J. G. Jardine

This study engineers SARS-CoV-2 neutralizing antibodies through directed evolution to enhance their potency and reduce viral escape.

bioRxiv · Jan 6, 2022 · PreprintBioengineering

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 delta variant

N. Hingankar, S. Deshpande, P. Das, Z. A. Rizvi, A. Burns, S. Barman, F. Zhao, M. Y. Ansari, S. Mukherjee, J. L. Torres, S. Chattopadhyay, F. Mehdi, J. Sutar, D. K. Rathore, K. Pargai, , J. Bhattacharya

This paper identifies two potent monoclonal antibodies from an Indian donor that neutralize SARS-CoV-2 variants including Delta, showing protection in a mouse model.

bioRxiv · Dec 25, 2021Immunology

Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus

F. Zhao, Z. T. Berndsen, N. Pedreno-Lopez, A. Burns, J. D. Allen, S. Barman, W.-H. Lee, S. Chakraborty, S. Gnanakaran, L. M. Sewall, G. Ozorowski, O. Limbo, G. Song, P. Yong, S. Callaghan, , D. Sok

This study identifies nAbs against SIVmac239, reveals structural features of its Env trimer, and shows passive transfer of nAbs protects macaques from infection.

bioRxiv · Dec 22, 2021Immunology

Broadening a SARS-CoV-1 neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution

F. Zhao, M. Yuan, C. Keating, N. Shabaani, O. Limbo, C. Joyce, J. Woehl, S. Barman, A. Burns, X. Zhu, M. Ricciardi, L. Peng, J. Smith, D. Huang, B. Briney, , J. G. Jardine

This paper describes engineering a SARS-CoV-1 neutralizing antibody to effectively neutralize SARS-CoV-2 through directed evolution and affinity maturation.

bioRxiv · May 29, 2021Bioengineering

One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening

I. Francino Urdaniz, P. J. Steiner, M. Kirby, F. Zhao, C. M. Haas, S. Barman, E. R. Rhodes, L. Peng, K. Sprenger, J. Jardine, T. A. Whitehead

The paper presents a method to identify SARS-CoV-2 Spike RBD escape mutants using yeast screening and provides associated resources.

bioRxiv · Mar 15, 2021Biochemistry